Skip to content
Z Zendikt
Editorial verdict · Who it’s wrong for

Who shouldn’t buy Pave?

A direct read on the buyers Pave is the wrong fit for — sourced from the same editorial team that ranked the full Compensation Management category.

Worst for

Enterprise sales-comp-heavy organizations (Beqom better for sales incentive depth), regulated industries needing deep pay equity audit (Compaas better fit), or budget-conscious SMBs (Aeqium cheaper for mid-market).

For context: who it IS for

Tech-forward mid-market and growth-stage companies (200-3,000 employees, $20M-$1B revenue) wanting real-time benchmarking, modern UX, and offer-letter automation integrated with their ATS.

Target size: 200–3,000 · Tech-forward mid-market and growth-stage

Why we say this

Editorial pulled these weaknesses from Pave’s product card in our Top 10 Compensation Management Software for 2026:

  • ! 2024 valuation softening from 2022 $1.6B peak
  • ! Pricing has crept up over 2024-2025 as Pave moved upmarket
  • ! Support is hit-or-miss post-scaling
  • ! Planning workflow less mature than Beqom for complex enterprise comp
  • ! Sales incentive compensation features below Beqom

If Pave is wrong for you, consider these instead

Same Compensation Management category, different best-fit buyer.

Related editorial

Last updated 2026-05-09. Editorial verdict based on the published Top 10 Compensation Management Software for 2026 ranking. Disagree? Tell us.